Patients with depression typically exhibit dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis, elevated concentrations of adrenocorticotropic hormone (ACTH) and cortisol, increased production of inflammatory factors, and upregulation of osteoclast activity, ultimately resulting in aberrant bone metabolism (36). Here, POMC is linked to major depressive disorder.